Aaron Wealth Advisors LLC Lipocine Inc. Transaction History

Aaron Wealth Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$0.37 - $8.65 $3,365 - $78,680	-9,096 Reduced 20.19%	35,949 $0
Q3 2022 Oct 21, 2022	SELL	$0.49 - $7.65 $49,000 - $765,000	-100,000 Reduced 68.94%	45,045 $20,000
Q2 2022 Jul 22, 2022	BUY	$0.73 - $1.34 $20,069 - $36,840	27,493 Added 23.39%	145,045 $116,000
Q1 2022 May 10, 2022	BUY	$0.89 - $1.85 $104,621 - $217,471	117,552 New	117,552 $85.8 Million
Q2 2021 Jul 29, 2021	SELL	$1.17 - $1.59 $17,550 - $23,850	-15,000 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$1.38 - $2.28 $20,700 - $34,200	15,000 New	15,000 $22,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $418M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Aaron Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Aaron Wealth Advisors LLC with notifications on news.